by Team Small News | Mar 29, 2025 | Dr Reddy's, Pharma
Dr. Reddy’s Laboratories, an Indian drugmaker, has secured regional rights to two biosimilars developed by Bio-Thera, a Chinese biotech company. The agreement grants Dr. Reddy’s the right to develop, manufacture, and market the biosimilars, which are... by Team Small News | Mar 29, 2025 | Dr Reddy's, Pharma
According to a recent article from Scrip, Dr. Reddy’s Laboratories has secured regional rights to a pair of biosimilars from Bio-Thera, a Chinese biotech company. The agreement grants Dr. Reddy’s the rights to commercialize Bio-Thera’s pegfedimondas... by Team Small News | Mar 26, 2025 | Dr Reddy's, Pharma
Dr. Reddy’s Laboratories (DRL) has announced that its subsidiary, Dr. Reddy’s Laboratories SA, has entered into a commercialization and licensing agreement with Bio-Thera Solutions, a Chinese biopharmaceutical company, to develop and market biosimilars of... by Team Small News | Mar 15, 2025 | Dr Reddy's, Pharma
Dr. Reddy’s, an Indian pharmaceutical company, has sold a portfolio of 14 Abbreviated New Drug Applications (ANDAs) to Ahmedabad-based Senores Pharmaceuticals. The acquired portfolio consists of 13 already approved ANDAs by the US Food and Drug Administration...